NO20074880L - Proteaseinhibitor forloper syntese - Google Patents

Proteaseinhibitor forloper syntese

Info

Publication number
NO20074880L
NO20074880L NO20074880A NO20074880A NO20074880L NO 20074880 L NO20074880 L NO 20074880L NO 20074880 A NO20074880 A NO 20074880A NO 20074880 A NO20074880 A NO 20074880A NO 20074880 L NO20074880 L NO 20074880L
Authority
NO
Norway
Prior art keywords
synthesis
protease inhibitor
proceeds
inhibitor proceeds
processes
Prior art date
Application number
NO20074880A
Other languages
English (en)
Norwegian (no)
Inventor
Bruno Linclau
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20074880L publication Critical patent/NO20074880L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Peptides Or Proteins (AREA)
NO20074880A 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese NO20074880L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101462 2005-02-25
US68369905P 2005-05-23 2005-05-23
PCT/EP2006/060246 WO2006089942A1 (en) 2005-02-25 2006-02-24 Protease inhibitor precursor synthesis

Publications (1)

Publication Number Publication Date
NO20074880L true NO20074880L (no) 2007-09-25

Family

ID=36646227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074880A NO20074880L (no) 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese

Country Status (19)

Country Link
US (2) US8067463B2 (ko)
EP (1) EP1856125B1 (ko)
JP (1) JP5260965B2 (ko)
KR (1) KR101333627B1 (ko)
CN (1) CN101128469B (ko)
AT (1) ATE440848T1 (ko)
AU (1) AU2006217922B2 (ko)
BR (1) BRPI0607827B8 (ko)
CA (1) CA2595295C (ko)
DE (1) DE602006008751D1 (ko)
DK (1) DK1856125T3 (ko)
ES (1) ES2331257T3 (ko)
IL (1) IL184519A (ko)
MX (1) MX2007010378A (ko)
NO (1) NO20074880L (ko)
PL (1) PL1856125T3 (ko)
PT (1) PT1856125E (ko)
RU (1) RU2421459C2 (ko)
WO (1) WO2006089942A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288153B2 (ja) * 2007-03-30 2013-09-11 日油株式会社 糖アルコール誘導体およびアルケニル基含有糖アルコール誘導体の製造方法
US8802724B2 (en) * 2010-11-30 2014-08-12 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
CN116102569A (zh) * 2021-11-11 2023-05-12 深圳容金科技有限公司 一种展青霉素半抗原的合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1088098B2 (en) 1998-06-23 2015-07-01 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Fitness assay and methods for reducing resistance of hiv to therapy
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
EP1089328A1 (en) * 1999-09-29 2001-04-04 Infineon Technologies AG Method for manufacturing of a semiconductor device
DE60039244D1 (de) 1999-10-06 2008-07-31 Tibotec Pharm Ltd HEXAHYDROFUROi2,3-B FURAN-3-YL-N- 3-i(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO -1-BENZYL-2-HYDROXYPROPYL CARBAMAT ALS RETROVIRUSPROTEASEHEMMER
DE60215623T2 (de) 2001-02-14 2007-08-30 Tibotec Pharmaceuticals Ltd. Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren
US7244752B2 (en) 2001-04-09 2007-07-17 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
EP1387842B1 (en) 2001-05-11 2009-04-22 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
US7087373B2 (en) 2001-06-05 2006-08-08 Tibotec Pharmaceuticals Ltd. Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
AR037797A1 (es) 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
TWI336621B (en) 2001-12-21 2011-02-01 Tibotec Pharm Ltd Broad spectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
EP1483254A4 (en) 2002-01-07 2005-06-08 Sequoia Pharmaceuticals INHIBITORS OF ANTI-RESISTANCE RETROVIRAL PROTEASE
AU2003208751A1 (en) 2002-02-22 2003-09-09 Tibotec Bvba Methods for determining the influence of protein binding on antiretroviral activity
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
CA2481285A1 (en) 2002-04-26 2003-11-06 Gilead Sciences, Inc. Non nucleoside reverse transcriptase inhibitors
JP4864320B2 (ja) 2002-05-16 2012-02-01 テイボテク・フアーマシユーチカルズ・リミテツド Ｈｉｖプロテアーゼ阻害剤の疑似多形相
JP4674084B2 (ja) 2002-05-17 2011-04-20 テイボテク・フアーマシユーチカルズ・リミテツド 広域スペクトルの置換ベンズイソキサゾールスルホンアミドｈｉｖプロテアーゼ阻害剤
AU2003254500B2 (en) 2002-07-01 2009-11-19 Tibotec Pharmaceuticals Ltd. Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance

Also Published As

Publication number Publication date
CN101128469A (zh) 2008-02-20
AU2006217922A1 (en) 2006-08-31
RU2007135345A (ru) 2009-03-27
AU2006217922B2 (en) 2012-04-05
WO2006089942A8 (en) 2007-12-13
BRPI0607827B1 (pt) 2019-11-05
CA2595295A1 (en) 2006-08-31
CA2595295C (en) 2014-07-08
DK1856125T3 (da) 2009-12-07
MX2007010378A (es) 2007-09-25
US8183394B2 (en) 2012-05-22
PT1856125E (pt) 2009-11-06
ES2331257T3 (es) 2009-12-28
EP1856125A1 (en) 2007-11-21
US8067463B2 (en) 2011-11-29
US20120041215A1 (en) 2012-02-16
EP1856125B1 (en) 2009-08-26
IL184519A0 (en) 2007-10-31
KR20080005183A (ko) 2008-01-10
BRPI0607827A2 (pt) 2009-10-06
DE602006008751D1 (de) 2009-10-08
BRPI0607827B8 (pt) 2021-05-25
WO2006089942A1 (en) 2006-08-31
JP2008531522A (ja) 2008-08-14
CN101128469B (zh) 2012-11-14
JP5260965B2 (ja) 2013-08-14
RU2421459C2 (ru) 2011-06-20
IL184519A (en) 2012-01-31
US20090054668A1 (en) 2009-02-26
KR101333627B1 (ko) 2013-11-27
PL1856125T3 (pl) 2010-01-29
ATE440848T1 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
DE602007012559D1 (de) H die schleimhaut
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
ATE453670T1 (de) Acrylierte hyaluronsäure
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
ATE429417T1 (de) Hiv-protease-inhibitoren
DK1480491T3 (da) Tynd højttaler samt fremgangsmåde til fremstilling deraf
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
NO20074880L (no) Proteaseinhibitor forloper syntese
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
SG158860A1 (en) Processes for the preparation of aminoethoxybenzyl alcohols
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
BRPI0607390A2 (pt) Processo para recuperar cci-779 de licores mâe
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
ITMI20060488A1 (it) Procedimento per la preparazione di 3,4-bis trifluoronetil-n-metilbenzilammina
UA94391C2 (ru) Синтез предшественника ингибитора протеазы
EA200802065A1 (ru) Синтез замещённых флуоренов
TW200740366A (en) Novel fluorescent cichlid and method for producing thereof
ATE464280T1 (de) Synthese von idarubin-aglycon

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: JANSSEN SCIENCES IRELAND UC, IE

FC2A Withdrawal, rejection or dismissal of laid open patent application